76 related articles for article (PubMed ID: 35530332)
1. Neoadjuvant Chemoradiotherapy Changes the Landscape of Soluble Immune Checkpoint Molecules in Patients With Locally Advanced Rectal Cancer.
Liu C; Wang P; Sun Y; Dou X; Hu X; Zou W; Sun Y; Hu Q; Yue J
Front Oncol; 2022; 12():756811. PubMed ID: 35530332
[TBL] [Abstract][Full Text] [Related]
2. Predicting the Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Using Soluble Immune Checkpoints.
Ari A; Sevik H; Sevinc MM; Tatar C; Buyukasik K; Surel AA; Idiz UO
Cancer Biother Radiopharm; 2024 Apr; 39(3):247-254. PubMed ID: 38010745
[No Abstract] [Full Text] [Related]
3. Immune Checkpoint Axes Are Dysregulated in Patients With Alcoholic Hepatitis.
Li W; Xia Y; Yang J; Guo H; Sun G; Sanyal AJ; Shah VH; Lou Y; Zheng X; Chalasani N; Yu Q
Hepatol Commun; 2020 Apr; 4(4):588-605. PubMed ID: 32258953
[TBL] [Abstract][Full Text] [Related]
4. MRI Tumor Regression Grade Combined with T2-Weighted Volumetry May Predict Histopathological Response in Locally Advanced Rectal Cancer following Neoadjuvant Chemoradiotherapy-A New Scoring System Proposal.
Jankovic A; Kovac JD; Dakovic M; Mitrovic M; Saponjski D; Milicevic O; Djuric-Stefanovic A; Barisic G
Diagnostics (Basel); 2023 Oct; 13(20):. PubMed ID: 37892047
[TBL] [Abstract][Full Text] [Related]
5. The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study.
Liang Y; Zhu Y; Lin H; Zhang S; Li S; Huang Y; Liu C; Qu J; Liang C; Zhao K; Li Z; Liu Z
BMC Cancer; 2021 Jun; 21(1):729. PubMed ID: 34172021
[TBL] [Abstract][Full Text] [Related]
6. Body composition parameters combined with blood biomarkers and magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Yang J; Deng Q; Chen Z; Chen Y; Fu Z
Front Oncol; 2023; 13():1242193. PubMed ID: 38074647
[TBL] [Abstract][Full Text] [Related]
7. Predicting Neoadjuvant Chemoradiotherapy Response in Locally Advanced Rectal Cancer Using Tumor-Infiltrating Lymphocytes Density.
Xu Y; Lou X; Liang Y; Zhang S; Yang S; Chen Q; Xu Z; Zhao M; Li Z; Zhao K; Liu Z
J Inflamm Res; 2021; 14():5891-5899. PubMed ID: 34785927
[TBL] [Abstract][Full Text] [Related]
8. Use of patient-derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Xue W; Wang T; Yao J; Wu W; Chen D; Yan B; Dong X; Tang Y; Zeng Y; He Y; Cao P; Shao F; Huang W; Deng C; Yan J
Bioeng Transl Med; 2023 Nov; 8(6):e10586. PubMed ID: 38023722
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Infiltrating Cytotoxic T Cells and Tumor-Associated Macrophages Correlate With the Outcomes of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
Yang Y; Tian W; Su L; Li P; Gong X; Shi L; Zhang Q; Zhao B; Zhao H
Front Oncol; 2021; 11():743540. PubMed ID: 34733785
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment Microvessel Density for Predicting of Tumor Responsiveness to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer.
Boonya-Ussadorn C; Nimmanon T; Anannamcharoen S
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2697-2703. PubMed ID: 37642056
[TBL] [Abstract][Full Text] [Related]
11. LncRNAs Associated with Chemoradiotherapy Response and Prognosis in Locally Advanced Rectal Cancer.
Zhang Y; Guan B; Wu Y; Du F; Zhuang J; Yang Y; Guan G; Liu X
J Inflamm Res; 2021; 14():6275-6292. PubMed ID: 34866926
[TBL] [Abstract][Full Text] [Related]
12. Interaction between intratumoral microbiota and tumor mediates the response of neoadjuvant therapy for rectal cancer.
Sun L; Qu J; Ke X; Zhang Y; Xu H; Lv N; Leng J; Zhang Y; Guan A; Feng Y; Sun Y
Front Microbiol; 2023; 14():1229888. PubMed ID: 37901832
[TBL] [Abstract][Full Text] [Related]
13. Lipid metabolism-associated genes serve as potential predictive biomarkers in neoadjuvant chemoradiotherapy combined with immunotherapy in rectal cancer.
Peng Q; Tao J; Xu Y; Shen Y; Wang Y; Jiao Y; Mao Y; Zhu Y; Liu Y; Tian Y
Transl Oncol; 2024 Jan; 39():101828. PubMed ID: 38000147
[TBL] [Abstract][Full Text] [Related]
14. Peripheral Soluble Immune Checkpoint-Related Proteins Were Associated with Survival and Treatment Efficacy of Osteosarcoma Patients, a Cohort Study.
Li B; Wang Q; Luo Y; Wang S; Pan S; Zhao W; Ye Z; Wu X
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730580
[TBL] [Abstract][Full Text] [Related]
15. Implications of Rectal Cancer Radiotherapy on the Immune Microenvironment: Allies and Foes to Therapy Resistance and Patients' Outcome.
Sartorius D; Blume ML; Fleischer JR; Ghadimi M; Conradi LC; De Oliveira T
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958298
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-β1 and soluble co-inhibitory immune checkpoints as putative drivers of immune suppression in patients with basal cell carcinoma.
Kgokolo MCM; Malinga NZ; Steel HC; Meyer PWA; Smit T; Anderson R; Rapoport BL
Transl Oncol; 2024 Apr; 42():101867. PubMed ID: 38308919
[TBL] [Abstract][Full Text] [Related]
17. sCD163, sCD28, sCD80, and sCTLA-4 as soluble marker candidates for detecting immunosenescence.
Aprilia A; Handono K; Sujuti H; Sabarudin A; Winaris N
Immun Ageing; 2024 Jan; 21(1):9. PubMed ID: 38243300
[TBL] [Abstract][Full Text] [Related]
18. Radiomic texture analysis based on neurite orientation dispersion and density imaging to differentiate glioblastoma from solitary brain metastasis.
Bai J; He M; Gao E; Yang G; Yang H; Dong J; Ma X; Gao Y; Zhang H; Yan X; Zhang Y; Cheng J; Zhao G
BMC Cancer; 2023 Dec; 23(1):1231. PubMed ID: 38098041
[TBL] [Abstract][Full Text] [Related]
19. Soluble PD-L1: a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancer.
He Y; Zhang X; Zhu M; He W; Hua H; Ye F; Zhou X; Chen N; Li Y; Zhong W; Wu G; Cai H; Jiang W
J Transl Med; 2023 Jan; 21(1):25. PubMed ID: 36639643
[TBL] [Abstract][Full Text] [Related]
20. Expression Pattern and Prognostic Value of CTLA-4, CD86, and Tumor-Infiltrating Lymphocytes in Rectal Cancer after Neoadjuvant Chemo(radio)therapy.
Yin XK; Wang C; Feng LL; Bai SM; Feng WX; Ouyang NT; Chu ZH; Fan XJ; Qin QY
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
